2009

PharmWeb GMP Forum

• Re: Batch Records Review Responsibility, Madhusudan Viswanathan (by way of John Dolman<info@the-dolman-consultancy.com>)
• Re: drugn product degradent, Brian MATTHEWS" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: drugn product degradent, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: drugn product degradent, Frank W (by way of John Dolman<info@the-dolman-consultancy.com>)
  • drugn product degradent, D WARD (by way of John Dolman<info@the-dolman-consultancy.com>)
• RE: qualification of working reference standards, Bob Kirsch" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: qualification of working reference standards, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
• RE; drugn product degradent, rajaneesh.br" (by way of JohnDolman <info@the-dolman-consultancy.com>)
• Re: Contamination, Rodny makenzy (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: Contamination, Jean-Denis Mallet (by way of John Dolman<info@the-dolman-consultancy.com>)
• Importation from outside the EU, Downing, Andrew" (by way ofJohn Dolman <info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: Importation from outside the EU, Brian MATTHEWS" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Importation from outside the EU, Jean-Denis Mallet (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Importation from outside the EU, Downing, Andrew" (by way ofJohn Dolman <info@the-dolman-consultancy.com>)
  • RE: Importation from outside the EU, Newbery, Alan" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: Importation from outside the EU, alan" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: Importation from outside the EU, alan" (by way of John Dolman<info@the-dolman-consultancy.com>)
• Empty chamber run in Depyrogenation Tunnel, Tzafrir" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: Empty chamber run in Depyrogenation Tunnel, RAJESH PAI (by way of John Dolman<info@the-dolman-consultancy.com>)
• Issueing COA for ANDA batch, Ranjith Gamage" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: Issueing COA for ANDA batch, Frank Bales" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Issueing COA for ANDA batch, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
• Re: Residual Solvents Testing, shakeel.salam" (by way of John Dolman<info@the-dolman-consultancy.com>)
• Raw Material labelling, Anita " (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: Raw Material labelling, aks (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: Raw Material labelling, (by way of John Dolman<info@the-dolman-consultancy.com>)
• Sampling plans, Tom Smith (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • RE: Sampling plans, MANITARAS CHRISTOS (by way of JohnDolman <info@the-dolman-consultancy.com>)
  • Re: Sampling plans, Amer Almalakh (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: Sampling plans, Newbery, Alan" (by way of John Dolman<info@the-dolman-consultancy.com>)
• Deviation Management, ambika" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: Deviation Management, Amer Almalakh (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: Deviation Management, Arvind Kushwaha" (by way ofJohn Dolman <info@the-dolman-consultancy.com>)
  • Re: Deviation Management, D WARD (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Deviation Management, kailash niranjan (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: Deviation Management, Owen Prichard (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Deviation Management, M.V Subbaraju" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Deviation Management, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
• LIMS FOR QC, Iyengar, Vasundhara" (by wayof John Dolman <info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: LIMS FOR QC, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: LIMS FOR QC, ambika" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: LIMS FOR QC, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: LIMS FOR QC, ambika" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: LIMS FOR QC, Frank Bales" (by way of John Dolman<info@the-dolman-consultancy.com>)
• cephalosporin injection-interlock design, lydia" (by way of John Dolman<info@the-dolman-consultancy.com>)
• Container Closure Suppliers Audit, Ed Lin" (by way of John Dolman<info@the-dolman-consultancy.com>)
• HCP Limits !, ambika" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: HCP Limits !, Bhavesh_Patel@Relbio.com (by way of John Dolman)
  • HCP Limits !, ambika" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: HCP Limits !, Bhavesh_Patel@Relbio.com (by way of John Dolman)
• OOT determination, Vanja Simovic" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • RE: OOT determination, Arvind Kushwaha" (by way ofJohn Dolman <info@the-dolman-consultancy.com>)
  • Re: OOT determination, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
  • OOT determination, Vanja Simovic" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: OOT determination, Arvind Kushwaha" (by way ofJohn Dolman <info@the-dolman-consultancy.com>)
  • Re: OOT determination, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
• Euipment Usage Log, ambika" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: Euipment Usage Log, Jean-Denis Mallet (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Frank Bales" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, SHAILESH_SAWANT@RELBIO.COM (by way of John Dolman)
  • RE: Euipment Usage Log, Arvind Kushwaha" (by way ofJohn Dolman <info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Amer Almalakh (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: Euipment Usage Log, Newbery, Alan" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Frank Bales" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Euipment Usage Log, ambika" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Jean-Denis Mallet (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Frank Bales" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Amer Almalakh (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, SHAILESH_SAWANT@RELBIO.COM (by way of John Dolman)
  • RE: Euipment Usage Log, Newbery, Alan" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Frank Bales" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: Euipment Usage Log, Arvind Kushwaha" (by way ofJohn Dolman <info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, P Rajendra (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Jean-Denis Mallet (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Euipment Usage Log, Ranjith Gamage (by way of John Dolman<info@the-dolman-consultancy.com>)
• Annual Stability, Anthony Mc Mahon" (by way of JohnDolman <info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Annual Stability, Anthony Mc Mahon" (by way of JohnDolman <info@the-dolman-consultancy.com>)
• Leak testing of FFS / BFS, Nimesh Solanki" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: Leak testing of FFS / BFS, SHAILESH_SAWANT@RELBIO.COM (by way of John Dolman)
  • Re: Leak testing of FFS / BFS, Jean-Denis Mallet (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Leak testing of FFS / BFS, SHAILESH_SAWANT@RELBIO.COM (by way of John Dolman)
  • Leak testing of FFS / BFS, Nimesh Solanki" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Leak testing of FFS / BFS, Jean-Denis Mallet (by way of John Dolman<info@the-dolman-consultancy.com>)
• No Subject, Frank Bales" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • No Subject, Frank Bales" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • No Subject, Frank Bales" (by way of John Dolman<info@the-dolman-consultancy.com>)
• Inquiry, Bipin Kumar" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Re: Inquiry, Ranjith Gamage (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Inquiry, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Inquiry, Bipin Kumar" (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Inquiry, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Inquiry, Ranjith Gamage (by way of John Dolman<info@the-dolman-consultancy.com>)
  • Re: Inquiry, Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>)
• Changing the source of water, Rodny makenzy (by way of John Dolman<info@the-dolman-consultancy.com>)
  • <Possible follow-up(s)>
  • Changing the source of water, Rodny makenzy (by way of John Dolman<info@the-dolman-consultancy.com>)
  • RE: Changing the source of water, Globepharm /MAnisfeld" (by way of JohnDolman <info@the-dolman-consultancy.com>)